Company Profile
Updated: 26-OCT-09BioInvent International AB
International public company
Soelvegatan 41, Lund, S-223 70, Sweden
()46 046 286 85 50, 46 046 211 08 06 fax, http://www.bioinvent.com
Primary SIC: Pharmaceutical Preparations, Primary NAICS: Pharmaceutical Preparation Manufacturing
Description: Manufacturing: Development and production of pharmaceuticals integrating the selection and development of antibodies.
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
ThromboGenics and BioInvent Complete Phase I Patient Trial of Anti-PlGF Cancer Therapeutic TB-403 in Patients With Advanced Solid Tumours.
Angiogenesis Weekly; 12/4/2009; 1436 words; ...Brussels: THR) and BioInvent International AB (OMXS: BINV) announced...AACR-NCI-EORTC International Conference on Molecular...ThromboGenics and BioInvent to Roche under an...with both Roche and BioInvent, our partners on...
Roche could be eyeing takeover of Swedish BioInvent.
Nordic Business Report; 11/19/2009; 557 words; ...be eyeing takeover of Swedish BioInvent(C)1994-2009 M2 COMMUNICATIONS...2009 - Swedish biotech company BioInvent International AB (STO: BINV) has developed...should be interested in buying BioInvent, according to a recent analysis...
Paper says Roche might be tempted to buy Swedish BioInvent.
ADP News Nordic; 11/19/2009; 627 words; ...2009 - Swedish biotech company BioInvent International AB (STO:BINV) has developed...should be interested in buying BioInvent, according to a recent analysis...business daily Dagens Industri. BioInvent is now beginning to prove that...
AACR Roundup.
BIOWORLD Today; 11/18/2009; 995 words; ...results of proceedings at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics...o ThromboGenics NV, of Leuven, Belgium, and BioInvent International AB, of Lund, Sweden, announced positive results...
Other News To Note.(University of Rome)(Apogenix GmbH)(brief)
BioWorld International; 11/18/2009; 2334 words; ...Scientists meeting in Los Angeles. o BioInvent International AB, of Lund, Sweden, entered...Daiichi will get access to BioInvent's technology platform and...fund all research work, while BioInvent is entitled to royalties for...
Recent News Articles
- Thrombogenics/BioInvent's TB-402 enters Ph I trial.(BioInvent International AB)(Brief article)
Pharma Marketletter - February 19, 2007 - Genentech-Bioinvent.(Pharma briefs)(BioInvent International AB)(Brief article)
Chemistry and Industry - January 29, 2007 - EU grant for ThromboGenics and BioInvent.(ThromboGenics NV and BioInvent International AB )(Brief article)
Pharma Marketletter - January 08, 2007 - BioInvent's losses fall 20% in 1st-half of 2006.(financial report of BioInvent International AB)(Financial report)(Brief article)
Pharma Marketletter - July 24, 2006
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning